Chemoinformaics analysis of STIGMAST-4-EN-3-ONE
| Molecular Weight | 412.702 | nRot | 6 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 21 |
| Exact Molecular Weight | 412.371 | nRing | 4 |
| Solubility: LogS | -6.934 | nHRing | 0 |
| Solubility: LogP | 7.65 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 81.2381 |
| nHD | 0 | BPOL | 49.0219 |
| QED | 0.401 |
| Synth | 4.41 |
| Natural Product Likeliness | 2.593 |
| NR-PPAR-gamma | 0.511 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.546 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.838 |
| MDCK | 0.00000696 |
| BBB | 0.979 |
| PPB | 0.980503 |
| VDSS | 1.846 |
| FU | 0.0146075 |
| CYP1A2-inh | 0.046 |
| CYP1A2-sub | 0.492 |
| CYP2c19-inh | 0.101 |
| CYP2c19-sub | 0.957 |
| CYP2c9-inh | 0.112 |
| CYP2c9-sub | 0.482 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.401 |
| CYP3a4-inh | 0.248 |
| CYP3a4-sub | 0.809 |
| CL | 15.901 |
| T12 | 0.036 |
| hERG | 0.089 |
| Ames | 0.021 |
| ROA | 0.034 |
| SkinSen | 0.114 |
| Carcinogencity | 0.056 |
| EI | 0.013 |
| Respiratory | 0.959 |
| NR-Aromatase | 0.033 |
| Antiviral | No |
| Prediction | 0.678113 |